Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria - Wikidata - awgldk - TriplyDB

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

http://www.wikidata.org/entity/Q24605493

about

Proteomic profiling in multiple sclerosis clinical courses reveals potential biomarkers of neurodegeneration Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone First-Line Disease-Modifying Therapies in Paediatric Multiple Sclerosis Defining the clinical course of multiple sclerosis: the 2013 revisions.New and emerging disease modifying therapies for multiple sclerosis Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy Treatment with disease modifying drugs for people with a first clinical attack suggestive of multiple sclerosis Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis Fingolimod for relapsing-remitting multiple sclerosis Alemtuzumab for multiple sclerosis Memory rehabilitation for people with multiple sclerosis Teriflunomide for multiple sclerosis Dimethyl fumarate for multiple sclerosis Sodium channel blockers for neuroprotection in multiple sclerosis Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis Exercise therapy for fatigue in multiple sclerosis Cholinesterase inhibitors for rarer dementias associated with neurological conditions Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis Information provision for people with multiple sclerosis Alemtuzumab for multiple sclerosis Dimethyl fumarate for multiple sclerosis Carnitine for fatigue in multiple sclerosis Mycophenolate mofetil for relapsing-remitting multiple sclerosis Teriflunomide for multiple sclerosis Laquinimod for multiple sclerosis Fluoxetine for multiple sclerosis Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis Sodium channel blockers for neuroprotection in multiple sclerosis Mycophenolate mofetil for relapsing-remitting multiple sclerosis Laquinimod for multiple sclerosis Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis Intravenous immunoglobulin to prevent relapses during pregnancy and postpartum in multiple sclerosis Vaccines for preventing influenza in multiple sclerosis patients Pharmacological treatment for memory disorder in multiple sclerosis Rituximab for relapsing-remitting multiple sclerosis Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients Teriflunomide for multiple sclerosis Mitoxantrone for multiple sclerosis

P2860

Q21131975-593FD245-5BFE-46E6-AC4B-6AF94FB45D08 Q21146662-96B272F4-8657-4A25-9C4A-15BE7E0C388E Q21558407-30CFA8F2-A47C-440D-832C-11ADB3E6338E Q22241417-20307831-DB7D-469F-9182-D372F39727A0 Q22241654-EB54C6C5-9EF1-406A-B2AE-55C00A221A5C Q22242305-551B9C69-FF3D-4752-B007-E301E2736B4F Q22252578-C04C0C75-758B-4BE4-945C-A372F06942E1 Q24185806-7DB82F8E-03BC-4B89-964F-0F630A086C73 Q24185820-0382EE41-0520-4E72-A630-228670ECF664 Q24185882-46348B7C-D31C-4C68-B1B7-91D713A3533E Q24185899-CF88CB4B-B2FB-4A98-816D-D67351814494 Q24186011-356A1470-40C4-423D-9845-1BCA7AB740FE Q24186016-E3A0E9A8-73B4-4265-9158-B65C9FE6189E Q24186433-F323433C-9E29-4DDF-9CD1-B46942FC5C72 Q24186448-1DD8F738-0BAF-4110-AEFD-4AE633E88BD6 Q24187126-CBA5FA53-ECD2-4E50-B0E6-3239327380B1 Q24187235-9ECD21AB-B79C-4BBC-9454-D95B5581B36F Q24187428-02590CE4-A5B7-4977-A9D3-2FF692A7717B Q24188270-5F0F4435-B440-42E0-A71D-6E744252AD3D Q24194800-1CB6B29F-6EA3-46A0-B4A0-1A2B46EBC2FC Q24195040-4630F8A5-95A9-4B29-B652-1E08A5926700 Q24195076-4CF8ACC0-57F7-41BF-A895-BDF8E903C616 Q24197602-5CAC545B-39B6-47F1-BFC6-1343EB2BA20B Q24197748-822628C0-0083-4528-B4E9-4433842733A7 Q24197935-5D5E3473-5EA3-4E57-801F-06E0CDEDB2B4 Q24198146-9EB400BF-DB0D-437D-9751-A3FF225D22A8 Q24198180-30153865-8C7F-432B-B379-C80243CA75C5 Q24198247-332C5CD3-B73A-4B5F-851D-148DF5C69431 Q24200422-58F3C568-B3F9-47F8-BFEF-A7689B50B079 Q24200461-DF6B722D-4006-4714-8A09-771E1E33B19D Q24200517-492EB3E3-25DA-48F8-8A60-6E96220CDC6C Q24200527-06D033A6-C6F0-49C0-9245-77C9774D1538 Q24200823-73BAF60E-6EA1-4197-B40F-90E2B762F4B3 Q24201599-23A10555-9F6B-454C-98CA-DA3C1E636E08 Q24201719-83418918-C82D-4EC1-9CC2-1B5ACF0EB8DF Q24201735-4192F19E-15E6-4805-976E-3B8C49CE47AD Q24201928-2FB23A3D-D451-4A14-A0D2-6D55AA4D242B Q24202111-A9CAEBE3-EDB5-4A02-8405-C8A00DA3B28B Q24202177-CAA11DB0-86EA-48E9-93B0-92F6A5BC4179 Q24202866-BE2731F9-A7F2-4CA6-AAD5-91D6FBC6EC38

P2860

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

http://www.wikidata.org/entity/Q24605493

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

@ast

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

@en

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

@nl

type

label

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

@ast

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

@en

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

@nl

prefLabel

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

@ast

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

@en

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

@nl

P1433

Q24605493-FC560B58-83D3-456D-9D6B-40F0AA56553E

P1476

Q24605493-B30D055E-ED87-48EF-A318-4608C5ACF4D2

P2093

Q24605493-0666E362-181C-4897-8DF3-46948D219690

Q24605493-128ADAEB-F923-4BF0-A5A2-503024DF620B

Q24605493-158A2C18-CB9B-491E-87B5-16ED0A624D5D

Q24605493-19CF7BCE-37F9-462F-ACFA-04484DC8D812

Q24605493-2388A81A-4CCE-4D2E-87DA-28B615D1423A

Q24605493-4E2E9DDC-8BFF-4DD3-817F-8A2788F78BF1

Q24605493-5072A63F-6A49-42A7-A2D9-EE7B7BCF6EFE

Q24605493-596C15F3-3539-4C7A-9950-E7DC72DD6AA3

Q24605493-DD73DDEC-84DB-4E60-8663-4552F7757AB6

Q24605493-E916001D-9B5E-4402-82E4-F935C82AEFC7

P2860

Q24605493-019109D9-A442-4E0A-AAEB-1038F414D6D2

Q24605493-01BADB9B-A29A-41A8-B294-54AD9BFE1CE7

Q24605493-01D2892E-5284-4FB6-8DBE-1BCF5F136DED

Q24605493-042AA99D-7DBC-485B-90A0-651076A7F9DB

Q24605493-08B330FA-E1D8-4497-AEB1-69ED2EAF5966

Q24605493-08D7EC47-A271-4F61-82CA-66F38B90AED1

Q24605493-0C014CF8-0100-42CC-86AB-E694F3D24CBC

Q24605493-0E71FC11-1D95-4FA3-A5CC-A1C46BB4B4CA

Q24605493-0F78B9B7-6EC7-4136-8B85-940930ED39DF

Q24605493-0FB409AE-A6F3-449E-B42F-95C917B978A6

P304

Q24605493-8983A2ED-FDF5-4A81-877F-29AFB6603F9D

P31

Q24605493-0D48EEF6-B181-43E1-AADE-BBDDFEE00F76

P3181

Q24605493-37A21AD1-D92B-464E-B3A5-B898C690ABF5

P356

Q24605493-7657F12A-045A-4197-A002-703E441B8D5E

P407

Q24605493-9CF30610-452C-40E9-8184-F7121DBC529C

P433

Q24605493-646F6C4F-086D-4134-9B82-649F29C63D61

P478

Q24605493-7C2818C9-A588-4EED-B133-EAB572200AFC

P50

Q24605493-13000033-DA18-4D89-B9C0-E2A83B7B8D31

Q24605493-19B8A628-042A-4F2A-9DD0-C8C55E193FD8

Q24605493-43A6C729-0D89-4B0A-B280-91C617257AFA

Q24605493-4AE0E3FF-22E7-4779-9631-992B189837B9

Q24605493-6054E95B-542D-4EA2-8CC5-5B9E8085ABB9

Q24605493-F7B8F8A1-5B9C-4CED-B8FB-6189E66549F2

P577

Q24605493-12E44832-18D1-4EE1-839C-C808B6808296

P5875

Q24605493-9AB9746C-4A00-4D9A-AB0A-9794141D2F41

P698

Q24605493-4B66BFF2-C741-4D85-A9E2-65215ED1406F

P921

Q24605493-0feaa7fa-6bd3-40d2-90f8-cdef50ec8a43

Q24605493-3999A784-5615-405F-8137-B82FFD8D9FBB

P932

Q24605493-CBCA0CEC-C454-4B58-8641-78E211BBF3D0

P3181

P356

P1433

Annals of Neurology

P1476

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

@en

P2093

Brenda Banwell

http://www.w3.org/2001/XMLSchema#string

Brian Weinshenker

http://www.w3.org/2001/XMLSchema#string

Chris H Polman

http://www.w3.org/2001/XMLSchema#string

Fred D Lublin

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Cohen

http://www.w3.org/2001/XMLSchema#string

Jerry S Wolinsky

http://www.w3.org/2001/XMLSchema#string

Kazuo Fujihara

http://www.w3.org/2001/XMLSchema#string

Magnhild Sandberg-Wollheim

http://www.w3.org/2001/XMLSchema#string

Michel Clanet

http://www.w3.org/2001/XMLSchema#string

Paul O'Connor

http://www.w3.org/2001/XMLSchema#string

P2860

Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MR Imaging

3D MPRAGE improves classification of cortical lesions in multiple sclerosis

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging

Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?

Differential diagnosis of suspected multiple sclerosis: a consensus approach

P304

292-302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

74489

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ANA.22366

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Emmanuelle Waubant

Alan J Thompson

Michael Hutchinson

Massimo Filippi

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50349474

http://www.w3.org/2001/XMLSchema#string

P698

21387374

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3084507

http://www.w3.org/2001/XMLSchema#string